The Henry Ford Health System No Harm Campaign: A Comprehensive Model to Reduce Harm and Save Lives

2012 ◽  
Vol 38 (7) ◽  
pp. 318-AP1 ◽  
Author(s):  
William A. Conway ◽  
Susan Hawkins ◽  
Jack Jordan ◽  
Mary J. Voutt-Goos

Cancer ◽  
1998 ◽  
Vol 82 (S10) ◽  
pp. 2043-2046 ◽  
Author(s):  
Raymond Y. Demers ◽  
Robert A. Chapman ◽  
Michael H. Flasch ◽  
Cheryl Martin ◽  
Bruce D. McCarthy ◽  
...  
Keyword(s):  


2021 ◽  
Vol 4 (1) ◽  
pp. 1-5
Author(s):  
Poppy Diah Palupi ◽  
Veronika Jayaningsih

Drug Related Problems (DRPs) merupakan kejadian yang tidak diinginkan yang dialami oleh pasien dan berkaitan dengan pengobatan sehingga berpotensi mengganggu keberhasilan terapi. Penelitian ini bertujuan untuk mengetahui dan menganalisa DRPs yang terjadi pada pasien Chronic Kidney Disease (CKD) di instalasi rawat inap klinik Sari Medika kabupaten Semarang. Penelitian ini merupakan penelitian deskriptif dengan pengumpulan data secara retrospektif pada pasien CKD yang diperoleh dari data rekam medis. Pengambilan sampel menggunakan teknik purposive sampling. Acuan yang digunakan pada penelitian ini adalah Pharmacotherapy Handbook 9th edition 2015, Kidney Disease Improving Global Outcomes (KDIGO), The Renal Drug Handbook 3rd edition 2009, Panduan Praktik Klinis & Clinical Pathway Penyakit Jantung, Pembuluh Darah 2016, dan Henry Ford Health System 6th edition 2011. Hasil penelitian yang dilakukan pada 84 pasien CKD menunjukkan bahwa terdapat DRPs pada 66 pasien dengan kategori yaitu indikasi tanpa terapi (30.86%), terapi tanpa indikasi (6.17%), dosis sub terapi (1.23%), dosis obat berlebih (13.58%), pemilihan obat tidak tepat (45.68%), dan penderita gagal menerima obat (2.47%).



2016 ◽  
Vol 82 (3) ◽  
pp. 348
Author(s):  
D. Dankerlui ◽  
D. Parke ◽  
T. Prentiss ◽  
J. Zervos ◽  
A. Plum ◽  
...  


2020 ◽  
Vol 3;23 (6;3) ◽  
pp. E297-E304
Author(s):  
David Daewhan Kim

Background: Prescribing opioids has become a challenge. The US Drug Enforcement Agency (DEA) and Centers for Disease Control and Prevention (CDC) have become more involved, culminating in the March 2016 release of the CDC’s “Guidelines for Prescribing Opioids for Chronic Pain.” Objectives: Given the new guidelines, we wanted to see if there have been any changes in the numbers, demographics, physician risk factors, charges, and sanctions involving the DEA against physicians who prescribe opioids, when compared to a previous DEA database review from 1998 to 2006. Study Design: This study involved an analysis of the DEA database from 2004 to 2017. Setting: The review was conducted at the Henry Ford Health System Division of Pain Medicine. Method: After institutional review board approval at Henry Ford Health System, an analysis of the DEA database of criminal prosecutions of physician registrants from 2004-2017 was performed. The database was reviewed for demographic information such as age, gender, type of degree (doctor of medicine [MD] or doctor of osteopathic medicine [DO]), years of practice, state, charges, and outcome of prosecution (probation, sentencing, and length of sentencing). An internet-based search was performed on each registrant to obtain demographic data on specialty, years of practice, type of medical school (US vs foreign), board certification, and type of employment (private vs employed). Results: Between 2004 and 2017, Pain Medicine (PM) had the highest percentage of in-specialty action at 0.11% (n = 5). There was an average of 18 prosecutions per year vs 14 in the previous review. Demographic risk factors for prosecution demonstrated the significance of the type of degree (MD vs. DO), gender, type of employment (private vs. employed), and board certification status for rates of prosecution. Having a DO degree and being male were associated with significantly higher risk as well as being in private practice and not having board certification (P < .001). In terms of type of criminal charges as a percent of cases, possession with intent to distribute (n = 90) was most prevalent, representing 52.3% of charges, with new charges being prescribing without medical purpose outside the usual course of practice (n = 71) representing 41.3% of charges. Comparison of US graduates (MD/DO) vs. foreign graduates showed higher rates of DEA action for foreign graduates but this was of borderline significance (P = .072). Limitations: State-by-state comparisons could not be made. Specialty type was sometimes selfreported, and information on all opioid prosecutions could not be obtained. The previous study by Goldenbaum et al included data beyond DEA prosecution, so direct comparisons may be limited. Conclusion: The overall risk of DEA action as a percentage of total physicians is small but not insignificant. The overall rates of DEA prosecution have increased. New risk factors include type of degree (DO vs. MD) and being in private practice with a subtle trend toward foreign graduates at higher risk. With the trend toward less prescribing by previously high-risk specialties such as Family Medicine, there has been an increase in the relative risk of DEA action for specialties treating patients with pain such as PM, Physical Medicine and Rehabilitation, neurology, and neurosurgery bearing the brunt of prosecutions. New, more subtle charges have been added involving interpretation of the medical purpose of opioids and standard of care for their use. Key words: Certification, CDC, criminal, DEA, opioid, prescribing, prosecution, sanctions



Author(s):  
Mostafa Zamanian ◽  
Zohreh Karimmian

As one of the main national systems in any country, the health system has always been considered by governments. What distinguishes health system from other systems is that its purpose is directly related to the public health. Different countries adopt different structural patterns in this field but one can consider relatively common functions for a national health system which includes all functional aspects for this system. In recent years, attempts have been made for offering a comprehensive model in describing the functions. The OECD determined principles needed to offer an appropriate typology that should be independent of the names of health programs in different countries. In this chapter, it's tried to provide an overview of the proposed models for structures and functions of the health system and to propose a comprehensive model for it with an emphasis on theoretical aspects of public policy-making and binding functions in any national development system. This comprehensive model, provides the possibility to evaluate the success of a health system.



2016 ◽  
pp. 1228-1256
Author(s):  
Mostafa Zamanian ◽  
Zohreh Karimmian

As one of the main national systems in any country, the health system has always been considered by governments. What distinguishes health system from other systems is that its purpose is directly related to the public health. Different countries adopt different structural patterns in this field but one can consider relatively common functions for a national health system which includes all functional aspects for this system. In recent years, attempts have been made for offering a comprehensive model in describing the functions. The OECD determined principles needed to offer an appropriate typology that should be independent of the names of health programs in different countries. In this chapter, it's tried to provide an overview of the proposed models for structures and functions of the health system and to propose a comprehensive model for it with an emphasis on theoretical aspects of public policy-making and binding functions in any national development system. This comprehensive model, provides the possibility to evaluate the success of a health system.



ASA Monitor ◽  
2021 ◽  
Vol 85 (1) ◽  
pp. 44-44
Author(s):  
Kelly Jong


Sign in / Sign up

Export Citation Format

Share Document